Chembio Diagnostics Inc.

+0.02 (+3.52%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)21.75M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$8.5 Million
Adjusted EPS-$0.19
See more estimates
10-Day MA$0.64
50-Day MA$0.69
200-Day MA$1.53
See more pivots

Chembio Diagnostics Inc. Stock, NASDAQ:CEMI

555 Wireless Boulevard, Hauppauge, New York 11788
United States of America
Phone: +1.631.924.1135
Number of Employees: 337


Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing of rapid medical tests. It offers rapid point-of-care tests for infectious, tropical and fever, and respiratory diseases, handheld analyzers, and veterinary products. The firm distributes its products to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. The company was founded in 1985 and is headquartered in Hauppauge, NY.